TABLE 3.
Quantitative Viral Replication in Urine, Oral Wash, and Blood at Transplant and Posttransplant among 98 Donor and Recipient Pairs
| VIRUS | Donors at Transplant (Samples available in 95/98) | KIDNEY (N=83) | LIVER (N=15) | ||
|---|---|---|---|---|---|
|
|
|
||||
| Recipients at Transplant | Recipients Posttransplant | Recipients at Transplant | Recipients Posttransplant | ||
|
| |||||
| Number (quantitative range in copies/mL) | |||||
|
| |||||
| EBV | |||||
| - Any site | 21 (22%) | 28 (34%) | 34 (41%) | 5 (33%) | 3 (20%) |
| - Oral wash | 21 (50–183,200) | 26 (100–6,115,000) | 26 (200–1,844,700) | 5 (200–125,700) | 2 (1,700–13,600) |
| - Urine | 0 | 1 (11,900) | 1 (800) | 0 | 0 |
| - Whole blood | 2 (1300–2000) | 2 (200) | 18 (200–52,800) | 0 | 2 (300–46,300) |
|
| |||||
| CMV | |||||
| - Any site | 0 | 2 (2%) | 21 (25%) | 0 (0%) | 0 |
| - Oral wash | 0 | 1 (200) | 5 (200–300) | 0 | |
| - Urine | 0 | 1 (200) | 0 | 0 | |
| - Whole blood | 0 | 0 | 18 (100–388,600) | 0 | |
|
| |||||
| BKV | |||||
| - Any site | 17 (17%) | 10 (12%) | 29 (35%) | 1 (7%) | 4 (27%) |
| - Oral wash | 0 | 0 | 0 | 0 | 0 |
| - Urine | 17 (800–9,056,000) | 10 (900–102,900) | 25 (400–≥10,000,000) | 1 (102,900) | 2 (300–121,100) |
| - Whole blood | 1 (1300) | 0 | 12 (300–1,575,000) | 0 | 2 (21,880–358,800) |